Please login to the form below

Research Pipeline

This page shows the latest Research Pipeline news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: GSK unveils R&D plan, Keytruda OK'd for lymphoma by NICE

News from pharma, biotech and healthcare. 23andMe alliance part of GSK’s new research plan. ... GSK’s CEO Emma Walmsley (pictured) has restated her determination to revive the firm’s research pipeline in a statement this morning, ahead of an

Latest news

GSK: we won’t be splitting up any time soon

The company has 27 immunomodulatory new molecular entities (NME) in clinical trials, around 60% of its total clinical pipeline. ... GSK is investing $300m in the firm, and says a long-term partnership to exploit its genetic databases will help it advance
Daily brief: Novartis spends big on ezcema,

Novartis already has ZPL389 in its pipeline, a phase II ezcema treatment it gained with the acquisition of Ziarco two years ago. ... The company, based in London and New York, has four ongoing clinical programmes, one compassionate use programme and a
BenevolentAI claims AI first with new Cambridge facility

BenevolentAI claims AI first with new Cambridge facility. Says its new drug discovery and development base will cover the entire research process. ... The company has previously generated novel drug candidates to treat a range of complex and previously
Artificial intelligence firm licenses Janssen candidates for development

Janssen has licensed a number of pipeline candidates to a UK artificial intelligence company that wants to use technology to innovate the drug development process. ... The London-based firm said the agreement would enable it to accelerate its development
Top three therapeutic areas lead pharma’s pipeline

Top three therapeutic areas lead pharma’ s pipeline. Oncology dominates followed by CNS disorders and infectious diseases. ... Oncology, central nervous system (CNS) disorders and infectious diseases account for 68% of the overall pharmaceutical

More from news
Approximately 3 fully matching, plus 42 partially matching documents found.

Latest Intelligence

Heart failure therapy embarks on a new era

There are also a number of other drugs coming through the research pipelines. ... Pipeline growing. While Entresto and ivabradine promise to make a significant impact in HF, there are also a number of other investigational drugs coming through the
Eisai: Bucking the trend with R&D growth

Research pipeline. Research at Eisai is focused on three key areas: neuroscience, oncology and vascular/immunological diseases. ... Commercial expansion. But it's not just in research spending that Eisai is bucking industry trends.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

Sigma-Tau Pharmaceuticals appoints CEO

a time of development in the company, as it expands through registration, life-cycle management and commercialisation of its proprietary research and development pipeline. “
Adaptimmune appoints former GSK executives

He will also lead the development of the company's pipeline of research programmes.
MedDay appoints former Sanofi VP to board

MedDay, which was only formed in 2011, will welcome Goupit's knowledge of business development as it looks to expand with its pipeline of drugs for nervous system disorders such as ... Goupit said: “ I strongly believe that MedDay's product pipeline
Galapagos appoints Bart Filius as chief financial officer

As we move forward and the pipeline matures further, I look forward to bringing my experience in finance and M&A to Galapagos.”. ... pipeline company” to a research-focused biotech firm.

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Associate Scientific Director: Salary TBC

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Account Director, Healthcare Advertising Agency: Salary TBC

Senior Writer, Healthcare Advertising, London: Excellent package

Sudler London - Senior Medical Writer: Competitive

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Sudler London - Account Director: Competitive

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Editorial Director – Medical Education: Neg

Graduate Scientific Editor: DOE

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Account Manager- 4 days per week or full-time: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Senior Medical Writer, MedComms Agency: Salary TBC

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior Training Manager - Surrey: Competitive Salary &Bonus

Healthcare PR Senior Account Manager: Salary TBC

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Senior Medical Writer: Salary is DOE

Subscribe to our email news alerts

PMHub

Add my company

An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....